文献速递慢性肾脏病

线粒体DNA拷贝数与肾脏疾病进展风险的关联

Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-01-01

在慢性肾功能不全队列研究的2943名参与者中,中位随访6.5年期间有1077人发生CKD进展。调整已确立的危险因素后,线粒体DNA拷贝数最低三分位组相比最高三分位组的CKD进展风险更高(HR 1.28,95%CI 1.10-1.50),趋势P=0.002。在有白蛋白尿者中结果相似,但在无白蛋白尿者中无统计学显著关联(交互作用P<0.001)。

要点

  • 线粒体DNA拷贝数最低三分位组CKD进展风险高于最高三分位组(HR 1.28,95%CI 1.10-1.50)。
  • CKD进展发生率在最低三分位组最高(58.1/1000人年),最高三分位组为46.3/1000人年。
  • 有白蛋白尿者中三分位1 vs 3的HR为1.24(95%CI 1.05-1.47),无白蛋白尿者中无统计学显著关联。

核心结论

  • 较低线粒体DNA拷贝数与CKD患者更高的CKD进展风险相关,且独立于已确立的危险因素。

研究设计与样本

  • 慢性肾功能不全队列研究,纳入2943名参与者,线粒体DNA拷贝数由Illumina HumanOmni 1-Quad阵列线粒体单核苷酸多态性探针强度计算血清水平。
  • CKD进展定义为肾衰竭或eGFR较基线减半,采用Cox比例风险模型计算风险比。

主要发现

  • 中位随访6.5年,1077例发生CKD进展;参与者平均年龄58岁,45%为女性,48%自认黑人。
  • CKD进展发生率:三分位1为58.1/1000人年,三分位2为50.8/1000人年,三分位3为46.3/1000人年。
  • 调整已确立危险因素后,三分位1 vs 3的HR为1.28(95%CI 1.10-1.50),三分位2 vs 3的HR为0.99(95%CI 0.85-1.16),趋势P=0.002。
  • 有白蛋白尿者中三分位1 vs 3的HR为1.24(95%CI 1.05-1.47);无白蛋白尿者中三分位1 vs 3的HR为1.04(95%CI 0.70-1.53),交互作用P<0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Mitochondrial DNA copy number is a biomarker of mitochondrial function, which has been hypothesized to contribute to pathogenesis of CKD through podocyte injury, tubular epithelial cell damage, and endothelial dysfunction. The prospective association of mitochondrial DNA copy number with CKD progression has not been previously evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Chronic Renal Insufficiency Cohort study participants had serum levels of mitochondrial DNA copy number calculated from probe intensities of mitochondrial single nucleotide polymorphisms genotyped on the Illumina HumanOmni 1-Quad Array. CKD progression was defined as kidney failure or halving of eGFR from baseline. Cox proportional hazards models were used to calculate hazard ratios for mitochondrial DNA copy number and risk of CKD progression. RESULTS: Among 2943 participants, mean age was 58 years, 45% were women, and 48% self-identified as Black. There were 1077 patients who experienced CKD progression over a median follow-up of 6.5 years. The incidence rate of CKD progression was highest for those in the lowest tertile of mitochondrial DNA copy number (tertile 1, 58.1; tertile 2, 50.8; tertile 3, 46.3 per 1000 person-years). Risk for CKD progression was higher for participants with lower levels of mitochondrial DNA copy number after adjustment for established risk factors (for tertile 1 versus 3, hazard ratio, 1.28 [95% confidence interval, 1.10 to 1.50]; for tertile 2 versus 3, hazard ratio, 0.99 [95% confidence interval, 0.85 to 1.16]; trend P=0.002). Similar results were seen among those with albuminuria (for tertile 1 versus 3, hazard ratio, 1.24; 95% confidence interval, 1.05 to 1.47), but there were no statistically significant associations among individuals without albuminuria (for tertile 1 versus 3, hazard ratio, 1.04; 95% confidence interval, 0.70 to 1.53; interaction P<0.001). CONCLUSIONS: These findings suggest lower mitochondrial DNA copy number is associated with higher risk of CKD progression, independent of established risk factors among patients with CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. He WJ, Li C, Huang Z, et al. Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease. Clin J Am Soc Nephrol. 2022. PMID: 35777833. doi:10.2215/CJN.15551121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。